Omnicell Inc(OMCL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | 38.77 | EPS (ttm) | 0.85 | Insider Own | 3.4% | Shs Outstand | 45.6M | Perf Week | -5.83% |
| Market Cap | 1.50B | Forward P/E | 15.69 | EPS next Y | -7.88% | Insider Trans | -1.81% | Shs Float | 44.1M | Perf Month | -11.69% |
| Enterprise Value | 1.37B | PEG | 1.05 | EPS next Q | 0.42 | Inst Own | 106.51% | Short Float | 7.48% | Perf Quarter | -13.3% |
| Income | 0.04B | P/S | 1.2 | EPS this Y | 40.05% | Inst Trans | 6.54% | Short Ratio | 4.29 | Perf Half Y | -6.58% |
| Sales | 1.25B | P/B | 1.16 | EPS next 5Y | 14.94% | ROA | 1.89% | Short Interest | 3.29M | Perf YTD | -27.62% |
| Book/sh | 28.32 | P/C | 4.63 | EPS past 3/5Y | -28.87% -43% | ROE | 3.06% | 52W High | -36.75% ($51.84) | Perf Year | -1.47% |
| Cash/sh | 7.08 | P/FCF | 10.67 | Sales past 3/5Y | -2.94% 5.84% | ROIC | 2.64% | 52W Low | 12.84% ($29.06) | Perf 3Y | -40.02% |
| Dividend Est. | - | EV/EBITDA | 9.17 | EPS Y/Y TTM | 72.08% | Gross Margin | 44.77% | Volatility(W/M) | 3.31% 3.5% | Perf 5Y | -79.46% |
| Dividend TTM | - | EV/Sales | 1.1 | Sales Y/Y TTM | 8.45% | Oper. Margin | 4.73% | ATR (14) | 1.36 | Perf 10Y | -13.94% |
| Dividend Ex-Date | - | Quick Ratio | 1.4 | EPS Q/Q | 337.17% | Profit Margin | 3.13% | RSI (14) | 35.82 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.61 | Sales Q/Q | 7.45% | SMA20 | -5.06% ($34.54) | Beta | 0.99 | Target Price | $57.86 |
| Payout | - | Debt/Eq | 0.15 | Earnings | 2026/7/30 | SMA50 | -15.16% ($38.65) | Rel Volume | 0.63 | Prev Close | $32.25 |
| Employees | 3580 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | 101.07% 0.64% | SMA200 | -19.38% ($40.67) | Avg Volume(3M) | 0.77M | Price | $32.79 |
| IPO | 2001/8/7 | Option/Short | Yes/Yes | Trades | 7084 | Volume | 483,326 | Change | 1.67% |
Company
OMCL is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 A US healthcare technology company that provides automated medication management solutions for medical institutions. It combines automated drug dispensing and storage equipment, pharmacy robots, management software, and services to support hospitals and pharmacies in medication management and medication safety. The company has established itself as a healthcare technology provider that combines medication management automation with software and services.
Over the past 1 year, on the lower side
37% below its 1-year high.
OMCL makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +40.0% this year.
Tap to view numbers
The price looks about right
Trading at 38.8 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -40.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 106.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
AVRY 0.06%
XHE 0.02%
HEAL 0.02%
ACVT 0.02%
BRNY 0.01%It ranks #4 in the industry
Based on market cap of $1B.
OMCL $1B PER 38.8
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is OMCL?
OMCL belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of OMCL?
The market cap of OMCL is approximately $1.5B, ranking 2,332 within its sector.
What is the P/E ratio of OMCL?
OMCL has a P/E ratio of approximately 38.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OMCL?
OMCL has recorded a 52-week high of $51.84 and a low of $29.06.
